TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33513483

Group type: EXPERIMENTAL
Intervention: 0.4% FOS
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 0.8% FOS
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10 ng/L TPT + 0.4% FOS
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10 ng/L TPT + 0.8% FOS
Number of subjects: 18

Group type: COMPARATOR
Intervention: 10 ng/L TPT
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study: 32970035

Group type: EXPERIMENTAL
Intervention: Body-worn alarm (n = 41)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Bell-and-pad alarm (n = 45)
Number of subjects: 86
Study: 34342760

Group type: EXPERIMENTAL
Intervention: Standardized palpation of the temporalis muscle with a 2.0-kg stimulus intensity for 10 seconds
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Standardized palpation of the temporalis muscle with a 2.0-kg stimulus intensity for 5 seconds
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Standardized palpation of the temporalis muscle with a 2.0-kg stimulus intensity for 2 seconds
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Standardized palpation of the temporalis muscle with varying durations and intensities
Number of subjects: 32
Study: 34108175

Group type: EXPERIMENTAL
Intervention: OCTOPuS intervention
Number of subjects: 426
Study: 34415257

Group type: EXPERIMENTAL
Intervention: Hydrocolloid nasal dressing
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 80
Study: 33065813

Group type: EXPERIMENTAL
Intervention: Lurasidone 20-60 mg/d
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study: 35120269

Group type: EXPERIMENTAL
Intervention: Protective ballooning technique
Number of subjects: 340

Group type: COMPARATOR
Intervention: Jailed wire technique
Number of subjects: 340
Study: 33079570

Group type: EXPERIMENTAL
Intervention: Direct-acting oral anticoagulants (DOACs)
Number of subjects: 249
Study: 34035401

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 1723

Group type: COMPARATOR
Intervention: Placebo (not treated with colchicine)
Number of subjects: 1723
Study: 33860672

Group type: EXPERIMENTAL
Intervention: Midodrine 10 mg three-times a day for 5 days
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (no midodrine)
Number of subjects: 28
Study: 35973473

Group type: EXPERIMENTAL
Intervention: Sporopollenin exine capsules (SpECs) containing vitamin D
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitamin D alone
Number of subjects: 0
Study: 33774956

Group type: EXPERIMENTAL
Intervention: Oral omega 3 in standard dose along with oral isotretinoin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo along with oral isotretinoin
Number of subjects: 60
Study: 36149730

Group type: EXPERIMENTAL
Intervention: Traditional therapy (Group 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Traditional therapy and mobile health agent (Group 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mobile health agent (Group 3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment (Group 4)
Number of subjects: 0
Study: 34039871

Group type: EXPERIMENTAL
Intervention: MTX + 99Tc-MDP
Number of subjects: 177

Group type: COMPARATOR
Intervention: MTX
Number of subjects: 177

Group type: COMPARATOR
Intervention: 99Tc-MDP
Number of subjects: 177
Study: 33430476

Group type: EXPERIMENTAL
Intervention: Combined therapy (therapy on dry land and aquatic therapy with Ai Chi)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ai Chi aquatic therapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Dry land therapy (control group)
Number of subjects: 45
Study: 35042175

Group type: EXPERIMENTAL
Intervention: Intravaginal (IV) PGE2 (2 mg)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Intracervical (IC) PGE2 (0.5 mg)
Number of subjects: 212
Study: 34695832

Group type: EXPERIMENTAL
Intervention: Mother's bed incline at 45°
Number of subjects: 254

Group type: COMPARATOR
Intervention: Mother's bed incline at 15°
Number of subjects: 254
Study: 35109906

Group type: EXPERIMENTAL
Intervention: Topical fusidic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical hydrogen peroxide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simple wound care
Number of subjects: 0
Study: 34855609

Group type: EXPERIMENTAL
Intervention: StepMATE app with additional supports for walking (experimental group)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Basic, pedometer-like version of the StepMATE app (control group)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both groups (combined)
Number of subjects: 96
Study: 35918438

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral serratus anterior plane block (SAPB) with 3 mg/kg 0.25% ropivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Incision infiltration (II) with 3 mg/kg 0.75% ropivacaine
Number of subjects: 60
Study: 33978115

Group type: EXPERIMENTAL
Intervention: Octagon FOPNL
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Triangle FOPNL
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Circle FOPNL
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Traffic Light FOPNL
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Magnifier FOPNL
Number of subjects: 2400

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 2400
Study: 32648838

Group type: EXPERIMENTAL
Intervention: Music of the child's choice
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Lullaby music
Number of subjects: 150

Group type: COMPARATOR
Intervention: No music (control group)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Pharmacologic sedation
Number of subjects: 150
Study: 35246048

Group type: EXPERIMENTAL
Intervention: NTI (Nociceptive Trigeminal Inhibition) oral device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo device
Number of subjects: 0
Study: 34081923

Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccine recipients
Number of subjects: 2046

Group type: EXPERIMENTAL
Intervention: Bivalent HPV vaccine recipients
Number of subjects: 2046
Study: 36085130

Group type: EXPERIMENTAL
Intervention: Listening to the Qur'an during the postoperative period
Number of subjects: 112

Group type: COMPARATOR
Intervention: Natural environment audio and Fentanyl for pain relief (Control)
Number of subjects: 112
Study: 33452217

Group type: EXPERIMENTAL
Intervention: IntelliVue ECG
Number of subjects: 39

Group type: COMPARATOR
Intervention: Nellcor PO
Number of subjects: 39
Study: 33590594

Group type: EXPERIMENTAL
Intervention: Vibration stimulation during intramuscular injection
Number of subjects: 84

Group type: COMPARATOR
Intervention: Standard intramuscular injection without vibration stimulation
Number of subjects: 84
Study: 32938208

Group type: EXPERIMENTAL
Intervention: QSAR model using quadratic transfer function
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other S-shaped and V-shaped transfer functions
Number of subjects: 0
Study: 35701109

Group type: EXPERIMENTAL
Intervention: Concussion information (CI)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Non-concussion information (non-CI)
Number of subjects: 199
Study: 34587960

Group type: EXPERIMENTAL
Intervention: Online culturally informed intervention (n=34)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (n=38)
Number of subjects: 72
Study: 34340675

Group type: EXPERIMENTAL
Intervention: Complete intrafascial cysprostatectomy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional interfascial surgeries
Number of subjects: 44
Study: 35725523

Group type: EXPERIMENTAL
Intervention: Budesonide 256 µg/day
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study: 33276764

Group type: COMPARATOR
Intervention: Static stretching exercise
Number of subjects: 45

Group type: COMPARATOR
Intervention: Strengthening exercise in lengthened hamstring position
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45

Group type: COMPARATOR
Intervention: Height of patients
Number of subjects: 45
Study: 35260042

Group type: EXPERIMENTAL
Intervention: Hype Energy Drink (HED)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 35180319

Group type: EXPERIMENTAL
Intervention: Interconnected Systems Framework
Number of subjects: 0
Study: 35759521

Group type: EXPERIMENTAL
Intervention: Arm-cranking
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cycling
Number of subjects: 10
Study: 32162213

Group type: EXPERIMENTAL
Intervention: Willpower beliefs (nonlimited vs limited)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Health demands (OAK severity, BMI, depressive symptoms)
Number of subjects: 243
Study: 35909224

Group type: EXPERIMENTAL
Intervention: High-frequency telephone contacts (TEL) for CADG patients
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Abstinent drinking goal (ADG)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Conditional abstinence drinking goal (CADG)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (no contact)
Number of subjects: 240
Study: 34132695

Group type: EXPERIMENTAL
Intervention: Early prehospital tranexamic acid (TXA) administered within 1 hour from time of injury
Number of subjects: 238

Group type: COMPARATOR
Intervention: Delayed prehospital tranexamic acid (TXA) administered beyond 1 hour from time of injury
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Early prehospital tranexamic acid (TXA)
Number of subjects: 238
Study: 32706639

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemohormonal therapy (CHT) with androgen deprivation plus docetaxel (75 mg/m2 every 3 weeks for 6 cycles) and radical prostatectomy (RP)
Number of subjects: 788

Group type: COMPARATOR
Intervention: Radical prostatectomy (RP) alone
Number of subjects: 788
Study: 34977421

Group type: EXPERIMENTAL
Intervention: Digital health self-monitoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined digital health and community health worker support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual diabetes care
Number of subjects: 0
Study: 36041750

Group type: EXPERIMENTAL
Intervention: Sotatercept 0.3 or 0.7 mg·kg‐1 (placebo-crossed group)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Sotatercept (continued-sotatercept group)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo (initial control group)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Overall safety evaluation
Number of subjects: 106
Study: 33436053

Group type: EXPERIMENTAL
Intervention: Jin’s three‐needle acupuncture (JTN) combined with mirror therapy (MT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Jin’s three‐needle acupuncture (JTN)
Number of subjects: 0
Study: 32337679

Group type: EXPERIMENTAL
Intervention: Active PBM + physiotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham PBM + physiotherapy
Number of subjects: 30
Study: 35240478

Group type: EXPERIMENTAL
Intervention: Randomized controlled trials
Number of subjects: 2620

Group type: EXPERIMENTAL
Intervention: Longitudinal/observational studies
Number of subjects: 2620

Group type: EXPERIMENTAL
Intervention: Meta-analyses/systematic reviews/practice guidelines
Number of subjects: 2620

Group type: EXPERIMENTAL
Intervention: Non-randomized controlled trials
Number of subjects: 2620

Group type: EXPERIMENTAL
Intervention: Obstetrics and gynecology journals
Number of subjects: 2620

Group type: EXPERIMENTAL
Intervention: Peripheral vascular disease journals
Number of subjects: 2620

Group type: EXPERIMENTAL
Intervention: Emergency medicine journals
Number of subjects: 2620

Group type: COMPARATOR
Intervention: Surgery journals
Number of subjects: 2620

Group type: COMPARATOR
Intervention: Pediatrics journals
Number of subjects: 2620

Group type: COMPARATOR
Intervention: Pulmonary journals
Number of subjects: 2620
Study: 33962499

Group type: EXPERIMENTAL
Intervention: Herbal supplement (Combi-5) taken along with vitamin C and Zinc supplements
Number of subjects: 1

Group type: COMPARATOR
Intervention: Control not specified
Number of subjects: 1
Study: 33310864

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study: 35565744

Group type: EXPERIMENTAL
Intervention: 8% trehalose solution
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 6% trehalose solution
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 4% trehalose solution
Number of subjects: 22

Group type: COMPARATOR
Intervention: 8% glucose solution
Number of subjects: 22

Group type: COMPARATOR
Intervention: water
Number of subjects: 22
Study: 34520431

Group type: EXPERIMENTAL
Intervention: Targeted intravenous albumin infusions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 34289814

Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 50

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Visceral pain
Number of subjects: 50
Study: 33482890

Group type: EXPERIMENTAL
Intervention: N-acetyl-l-leucine (IB1001)
Number of subjects: 0
Study: 32916658

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (n = 14)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (n = 13)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 27
Study: 36078339

Group type: EXPERIMENTAL
Intervention: ADL-group (multiplanar everyday movements)
Number of subjects: 19
Study: 33539637

Group type: EXPERIMENTAL
Intervention: Active stimulation
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 39
Study: 32686874

Group type: EXPERIMENTAL
Intervention: 400 mg TCT daily
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 800 mg TCT daily
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 150
Study: 36376222

Group type: EXPERIMENTAL
Intervention: Endoscopic biliary drainage (EBD)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Percutaneous biliary drainage (PTBD)
Number of subjects: 54
Study: 33440964

Group type: EXPERIMENTAL
Intervention: Local oxygen therapy (LOT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 35276840

Group type: EXPERIMENTAL
Intervention: Zinc dispersible tablet
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient powder (MNP)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo powder
Number of subjects: 174
Study: 34506874

Group type: EXPERIMENTAL
Intervention: Endotracheal Intubation (ETI) during manual chest compressions
Number of subjects: 303

Group type: COMPARATOR
Intervention: Laryngeal Tube (LT) during manual chest compressions
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Endotracheal Intubation (ETI) during mechanical chest compressions
Number of subjects: 303

Group type: COMPARATOR
Intervention: Laryngeal Tube (LT) during mechanical chest compressions
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Comparison of ventilation per minute and duration of TI amplitude insufflation and exhalation
Number of subjects: 303
Study: 35223726

Group type: EXPERIMENTAL
Intervention: Non-refutational two-sided messages
Number of subjects: 1184

Group type: EXPERIMENTAL
Intervention: Refutational two-sided messages
Number of subjects: 1184

Group type: COMPARATOR
Intervention: One-sided messages
Number of subjects: 1184
Study: 32227161

Group type: EXPERIMENTAL
Intervention: Used a placebo analgesic cream
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Merely possessed a placebo analgesic cream
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Possessed and used a placebo analgesic cream
Number of subjects: 180

Group type: COMPARATOR
Intervention: Possessed a sham cream
Number of subjects: 180

Group type: COMPARATOR
Intervention: No cream
Number of subjects: 180
Study: 33705267

Group type: EXPERIMENTAL
Intervention: Diet ID
Number of subjects: 68

Group type: COMPARATOR
Intervention: ASA24
Number of subjects: 68
Study: 32890015

Group type: EXPERIMENTAL
Intervention: Magnesium infusion (50 mg kg-1 followed by 15 mg kg-1 h-1)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (0.9% saline infusion)
Number of subjects: 70
Study: 33677113

Group type: EXPERIMENTAL
Intervention: Immediate spa therapy (18 days)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Delayed spa therapy (after 6 months)
Number of subjects: 220
Study: 32565215

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 34871745

Group type: EXPERIMENTAL
Intervention: Antimicrobial stewardship intervention (ASI)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 149
Study: 32331062

Group type: EXPERIMENTAL
Intervention: Dasotraline (4, 6, and 8 mg/d)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 317
Study: 35137935

Group type: EXPERIMENTAL
Intervention: Melatonin (300 mg capsule)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 32020523

Group type: EXPERIMENTAL
Intervention: 30 mg/day zinc supplement
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 36018353

Group type: EXPERIMENTAL
Intervention: Native tissue surgery
Number of subjects: 1348

Group type: EXPERIMENTAL
Intervention: Biological xenograft surgery
Number of subjects: 1348

Group type: EXPERIMENTAL
Intervention: Polypropylene mesh surgery
Number of subjects: 1348
Study: 34074830

Group type: EXPERIMENTAL
Intervention: Kiwifruit (2/d)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Prunes (100 g/d)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Psyllium (12 g/d)
Number of subjects: 79
Study: 33100020

Group type: EXPERIMENTAL
Intervention: Insulin medications
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Non-insulin medications
Number of subjects: 263
Study: 34075612

Group type: EXPERIMENTAL
Intervention: P218 (up to 1000 mg)
Number of subjects: 56
Study: 33481808

Group type: EXPERIMENTAL
Intervention: Kato-Katz slides stored at room temperature
Number of subjects: 488

Group type: COMPARATOR
Intervention: Kato-Katz slides stored in a refrigerator
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Whole stool samples stored at room temperature for one day
Number of subjects: 488

Group type: COMPARATOR
Intervention: Whole stool samples stored in the refrigerator for one day
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Stirring whole stool samples
Number of subjects: 488
Study: 34058250

Group type: EXPERIMENTAL
Intervention: Group 1A: 2 sizes larger than the IABF with a 4% taper
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Group 1B: 2 sizes larger than the IABF with a 6% taper
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Group 2A: 3 sizes larger than the IABF with a 4% taper
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Group 2B: 3 sizes larger than the IABF with a 6% taper
Number of subjects: 120
Study: 32852611

Group type: EXPERIMENTAL
Intervention: Naturopathy, Yoga and Dietary interventions
Number of subjects: 116

Group type: COMPARATOR
Intervention: Psycho‐social counselling
Number of subjects: 116
Study: 33416294

Group type: EXPERIMENTAL
Intervention: Expectant management at 39 weeks of gestation
Number of subjects: 2502

Group type: EXPERIMENTAL
Intervention: Expectant management at 40 weeks of gestation
Number of subjects: 2502

Group type: EXPERIMENTAL
Intervention: Expectant management at 41-42 weeks of gestation
Number of subjects: 2502
Study: 33052454

Group type: COMPARATOR
Intervention: Urine NGAL levels in ALL survivors
Number of subjects: 86

Group type: COMPARATOR
Intervention: Urine NGAL/creatinine ratio in ALL survivors
Number of subjects: 86

Group type: COMPARATOR
Intervention: Urine KIM-1/creatinine ratio in ALL survivors
Number of subjects: 86

Group type: COMPARATOR
Intervention: Urine KIM-1 levels in ALL survivors after 5 years
Number of subjects: 86

Group type: COMPARATOR
Intervention: Urine NGAL levels in ALL survivors after 5 years
Number of subjects: 86

Group type: COMPARATOR
Intervention: eGFR in ALL survivors after 5 years
Number of subjects: 86
Study: 36042095

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Active Control Condition (ACC)
Number of subjects: 164
Study: 34338870

Group type: EXPERIMENTAL
Intervention: Preoperative MRI assessment of pelvic soft tissue measurements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgeon's intuitive assessment of surgical difficulty
Number of subjects: 0
Study: 32442189

Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine system (LNG-IUS)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Copper intrauterine device (C-IUD)
Number of subjects: 205
Study: 34941083

Group type: EXPERIMENTAL
Intervention: MNF scoring system (derived from clinical risk factors including female gender, age > 60 years, WBC ≤5000/mm3, WBC ≥35,000/mm3, creatinine ≥1.6 mg/dL, pulse rate >130/min)
Number of subjects: 1503

Group type: EXPERIMENTAL
Intervention: MNF scoring system (validation cohort)
Number of subjects: 1503
Study: 32705205

Group type: EXPERIMENTAL
Intervention: Bromfenac sodium (BS) after femtosecond laser-assisted cataract surgery (FLACS)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Femtosecond laser-assisted cataract surgery (FLACS) + DEX/TOB
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional phacoemulsification treatment (CPCS) + DEX/TOB
Number of subjects: 90

Group type: COMPARATOR
Intervention: FLACS + pranoprofen
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: FLACS + BS
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: In vitro studies with SRA01/04 cells treated with UV
Number of subjects: 90
Study: 36226829

Group type: EXPERIMENTAL
Intervention: 0-28 schedule of CoronaVac
Number of subjects: 2302

Group type: EXPERIMENTAL
Intervention: 0-14 schedule of CoronaVac
Number of subjects: 2302

Group type: COMPARATOR
Intervention: Both schedules of CoronaVac
Number of subjects: 2302
Study: 32451933

Group type: EXPERIMENTAL
Intervention: Sulodexide 500 lipasemic units (LSUs) twice daily
Number of subjects: 1450

Group type: EXPERIMENTAL
Intervention: Sulodexide 250 LSU twice daily + indistinguishable placebo
Number of subjects: 1450

Group type: COMPARATOR
Intervention: Indistinguishable placebo
Number of subjects: 1450

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 1450
Study: 32627975

Group type: EXPERIMENTAL
Intervention: Chin‐down‐plus‐larynx‐tightening maneuver during feeding
Number of subjects: 237

Group type: COMPARATOR
Intervention: Routine care (Control Group)
Number of subjects: 237